These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36638768)

  • 1. Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics.
    Ghadiri F; Sahraian MA; Razazian N; Ashtari F; Poursadeghfard M; Nabavi SM; Navardi S; Baghbanian SM; Shaygannejad V; Harirchian MH; Beladimoghadam N; Majdinasab N; Hosseini S; Azimi A; Kamali H; Sharifipour E; Hosseini Nejad Mir N; Bayati A; Nahayati MA; Heidari H; Mozhdehipanah H; Ghalyanchi Langroodi H; Jalali N; Ayoubi S; Asadollahzadeh E; Ebadi Z; Eskandarieh S; Naser Moghadasi A
    Mult Scler Relat Disord; 2023 Feb; 70():104493. PubMed ID: 36638768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and demographic characteristics of late-onset multiple sclerosis: LOMS-TR study.
    Sıvacı AÖ; Seferoğlu M; Piri Çınar B; Uzunköprü C; Beckmann Y; Güngör Doğan İ; Çetinkaya Tezer D; Tunç A; Ethemoğlu Ö; Gümüş H; Açıkgöz M; Yalaz Tekan Ü; Demir S
    Mult Scler Relat Disord; 2024 Apr; 84():105469. PubMed ID: 38341979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is late-onset multiple sclerosis associated with a worse outcome?
    Tremlett H; Devonshire V
    Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a late-onset multiple sclerosis Portuguese cohort.
    Moura J; Duarte S; Oliveira V; Pereira D; Costa D; Samões R; Sousa AP; Silva AM; Santos E
    Mult Scler Relat Disord; 2023 Feb; 70():104506. PubMed ID: 36638770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study.
    Guillemin F; Baumann C; Epstein J; Kerschen P; Garot T; Mathey G; Debouverie M;
    Neuroepidemiology; 2017; 48(3-4):179-187. PubMed ID: 28793296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Features of Late-Onset Multiple Sclerosis: a Systematic Review and Meta-analysis.
    Naseri A; Nasiri E; Sahraian MA; Daneshvar S; Talebi M
    Mult Scler Relat Disord; 2021 May; 50():102816. PubMed ID: 33571792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis.
    Mirmosayyeb O; Brand S; Barzegar M; Afshari-Safavi A; Nehzat N; Shaygannejad V; Sadeghi Bahmani D
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32370288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of patients with late-onset multiple sclerosis.
    Kis B; Rumberg B; Berlit P
    J Neurol; 2008 May; 255(5):697-702. PubMed ID: 18283394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifetime exposure to smoking and substance abuse may be associated with late-onset multiple sclerosis: a population-based case-control study.
    Abbasi Kasbi N; Ghane Ezabadi S; Kohandel K; Khodaie F; Sahraian AH; Nikkhah Bahrami S; Mohammadi M; Almasi-Hashiani A; Eskandarieh S; Sahraian MA
    BMC Neurol; 2024 Sep; 24(1):327. PubMed ID: 39243006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis: A Swedish Nationwide Study.
    Mouresan EF; Mentesidou E; Berglund A; McKay KA; Hillert J; Iacobaeus E
    Neurology; 2024 Mar; 102(6):e208051. PubMed ID: 38394472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-onset MS is associated with an increased rate of reaching disability milestones.
    Andersen MA; Buron MD; Magyari M
    J Neurol; 2021 Sep; 268(9):3352-3360. PubMed ID: 33677675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-onset multiple sclerosis: disability trajectories in relapsing-remitting patients of the Italian MS Registry.
    Lorefice L; Ferraro OE; Fenu G; Amato MP; Bresciamorra V; Conte A; De Luca G; Ferraro D; Filippi M; Gazzola P; Iaffaldano P; Inglese M; Lus G; Marfia GA; Patti F; Pesci I; Salemi G; Trojano M; Zaffaroni M; Monti MC; Cocco E;
    J Neurol; 2024 Apr; 271(4):1630-1637. PubMed ID: 38172380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-onset multiple sclerosis in Isfahan, Iran.
    Etemadifar M; Abtahi SH; Minagar A; Akbari M; Masaeli A; Tabrizi N
    Arch Iran Med; 2012 Oct; 15(10):596-8. PubMed ID: 23020533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
    Alroughani R; Akhtar S; Ahmed S; Behbehani R; Al-Hashel J
    PLoS One; 2016; 11(11):e0165846. PubMed ID: 27802328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of cognitive and physical characteristics in late-onset, adult-onset and early-onset multiple sclerosis patients.
    Ozakbas S; Kaya E; Aslan T; Ozdogar AT; Baba C
    Mult Scler Relat Disord; 2024 Oct; 90():105810. PubMed ID: 39180837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A national registry-based study of ethnic differences in people with multiple sclerosis in Iran.
    Ashtari F; Kavosh A; Baghbanian SM; Hosseini Nejad Mir N; Hosseini S; Razazian N; Majdinasab N; Farajzadegan Z; Shaygannejad V; Adibi I; Eskandarieh S; Sahraian MA
    Clin Neurol Neurosurg; 2024 Apr; 239():108216. PubMed ID: 38490075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time interval between the onset of symptoms and diagnosis of multiple sclerosis and the influential factors: A national registry-based study.
    Khodaie F; Moghadasi AN; Hosseinnataj A; Baghbanian SM; Ashtari F; Razazian N; Poursadeghfard M; Majdi-Nasab N; Hatamian H; Hoseini S; Nahayati MA; Nabavi SM; Faraji F; Harirchian MH; Mir NHN; Moghadam NB; Sharifipour E; Bayati A; Kamali H; Mozhdehipanah H; Jalali N; Abotorabi-Zarchi M; Kamyari N; Nikbakht R; Azimi A; Navardi S; Heidari H; Sahraian MA; Eskandarieh S
    Clin Neurol Neurosurg; 2024 Apr; 239():108221. PubMed ID: 38447483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of gender on late-onset multiple sclerosis.
    Bove RM; Healy B; Augustine A; Musallam A; Gholipour T; Chitnis T
    Mult Scler; 2012 Oct; 18(10):1472-9. PubMed ID: 22383227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Epidemiological Aspects of Late Onset Multiple Sclerosis in East-Azerbaijan, Iran; A Population-Based Study.
    Nasiri E; Naseri A; Abbasgholizadeh P; Fahidi A; Talebi M
    Arch Iran Med; 2022 Nov; 25(11):725-729. PubMed ID: 37543896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years.
    Ghadiri F; Sahraian MA; Baghbanian SM; Ashtari F; Razazian N; Majdinasab N; Poursadeghfard M; Hatamian H; Harirchian MH; Beladimoghadam N; Azimi A; Sharifipour E; Hosseini S; Bayati A; Kamali H; Hosseni Nejad Mir N; Faraji F; Mozhdehipanah H; Modara F; Navardi S; Heidari H; Ayoubi S; Naser Moghadasi A; Eskandarieh S
    Mult Scler Relat Disord; 2022 May; 61():103777. PubMed ID: 35390594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.